AIORTA Trademark

Trademark Overview

On Monday, September 9, 2024, a trademark application was filed for AIORTA with the United States Patent and Trademark Office. The USPTO has given the AIORTA trademark a serial number of 79408782. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, November 7, 2024. This trademark is owned by ViTAA Medical Solutions Inc.. The AIORTA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Software as a service (SaaS) for medical use, namely to perform assessment of the biomechanical properties of major blood vessels and predict pathophysiological outcomes such as growth or rupture.
aiorta

General Information

Serial Number79408782
Word MarkAIORTA
Filing DateMonday, September 9, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, November 7, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesSoftware as a service (SaaS) for medical use, namely to perform assessment of the biomechanical properties of major blood vessels and predict pathophysiological outcomes such as growth or rupture.

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, November 7, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameViTAA Medical Solutions Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCA

Trademark Events

Event DateEvent Description
Thursday, November 7, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, November 8, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 8, 2024APPLICATION FILING RECEIPT MAILED

Related Keywords

aiorta predict vessels blood pathophysiological outcomes rupture growth such major properties